In Depth 7 Jul 2025 Biotech in Vienna: a budding life science hub As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years. July 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Jul 2025 Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma. July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy Delve into the field of HIV treatment development. Since the virus was discovered, treatments have improved, but are we close to a cure? July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2025 Psychedelics sans side effects: neuroplastogens gain ground The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders. June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Jun 2025 ALS: how close are we to a cure? Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years. June 25, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Jun 2025 Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem Discover what makes Paris’s biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters in Europe. June 24, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Jun 2025 Stem cell therapy: a potential cure for hearing loss? As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss. June 20, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Jun 2025 From undruggable to oral therapy: The rise of STAT6 degraders Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. June 18, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 16 Jun 2025 Did Novo open the Canadian market to GLP-1 generics? Find out if Novo’s GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee? June 16, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2025 A new era in migraine treatment: Innovative drugs redefining the field Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better. June 13, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Jun 2025 Can gene therapy treat vision loss? Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness. June 11, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Jun 2025 The biggest biotech funding rounds in May 2025 The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in May 2025. June 4, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email